GlassScriptPhysician profile
Laura Apgar
NPI 1366222804
$1,614.89
in general payments reported to CMS, 2019-2025
10 companies · $992 in 2025
The $992 reported for 2025 was more than what 84% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $218 · 2024: $406 · 2025: $992.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,522 · Education: $92.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,521.90 |
| Education | $92.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $249.91 | 2025 | Carvykti, Rybrevant |
| Pfizer INC. | $248.97 | 2024-2025 | |
| Incyte Corporation | $226.23 | 2025 | Niktimvo |
| Adaptive Biotechnologies Corporation | $222.59 | 2025 | Clonoseq |
| Teleflex LLC | $125.92 | 2024 | Arrow |
| Puma Biotechnology, INC. | $123.97 | 2025 | |
| Seagen INC. | $116.52 | 2023 | Adcetris |
| Servier Pharmaceuticals LLC | $101.23 | 2023 | |
| Syndax Pharmaceuticals, INC. | $99.81 | 2025 | |
| Beigene USA, INC. | $99.74 | 2024 | Brukinsa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Apgar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.